Cargando…

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity

Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the Western world. The therapeutic approach to CLL includes chemotherapeutic regimens and immunotherapy. Complement-mediated cytotoxicity, which is one of the mechanisms activated by the therapeutic monoclonal antibodies, depend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michelis, Regina, Tadmor, Tamar, Barhoum, Masad, Shehadeh, Mona, Shvidel, Lev, Aviv, Ariel, Stemer, Galia, Dally, Najib, Rahimi-Levene, Naomi, Yuklea, Mona, Braester, Andrei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314568/ https://www.ncbi.nlm.nih.gov/pubmed/30601845 http://dx.doi.org/10.1371/journal.pone.0209024

Ejemplares similares

Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway
por: Michelis, Regina, et al.
Publicado: (2020)

Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia
por: Michelis, Regina, et al.
Publicado: (2022)

The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia
por: Naseraldeen, Naseba, et al.
Publicado: (2021)

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
por: Herishanu, Yair, et al.
Publicado: (2022)

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
por: Benjamini, Ohad, et al.
Publicado: (2021)

Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia
por: Tadmor, Tamar, et al.
Publicado: (2021)

P651: REAL-WORLD EFFECTIVENESS OF VENETOCLAX-BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL: UPDATE FROM THE MULTICENTER PROSPECTIVE REVEAL STUDY
por: Herishanu, Yair, et al.
Publicado: (2023)

Physicians’ lack of knowledge - a possible reason for red blood cell transfusion overuse?
por: Rahav Koren, Roni, et al.
Publicado: (2017)

Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy
por: Barki-Harrington, Liza, et al.
Publicado: (2021)

Timing of BNT162b2 vaccine prior to COVID‐19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study
por: Gutwein, Odit, et al.
Publicado: (2023)

Peripheral Blood Cell Mitochondrial Dysfunction in Myelodysplastic Syndrome Can Be Improved by a Combination of Coenzyme Q10 and Carnitine
por: Filanovsky, Kalman, et al.
Publicado: (2020)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023)

A Puzzling “Switch” in Blood Type Following Blood Transfusion
por: Akria, Luiza, et al.
Publicado: (2017)

Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration
por: Azoulay, David, et al.
Publicado: (2020)

Development and validation of a knowledge-driven risk calculator for critical illness in COVID-19 patients
por: Cahan, Amos, et al.
Publicado: (2021)

Safety and efficacy of ibrutinib in a patient with severe renal impairment
por: Filanovsky, Kalman, et al.
Publicado: (2017)

Can Gilbert's syndrome mitigate chronic lymphocytic leukemia?
por: Yavorkovsky, Leonid L, et al.
Publicado: (2022)

Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence
por: Stemer, Galia, et al.
Publicado: (2021)

All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia
por: Shmuely, Haim, et al.
Publicado: (2023)

THE STRUCTURAL BASIS FOR BINDING OF COMPLEMENT BY IMMUNOGLOBULIN M
por: Hurst, Mary M., et al.
Publicado: (1974)

Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients
por: Meerson, Ari, et al.
Publicado: (2019)

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway
por: Koro, Catalin, et al.
Publicado: (2014)

Influence of splenectomy on immunoglobulins and complement components in major thalassemia
por: Darzi, Ali Asghar, et al.
Publicado: (2015)

Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
por: Burnouf, Thierry, et al.
Publicado: (2022)

INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDES IN IMMUNOGLOBULIN-DEFICIENT SERA
por: Gewurz, H., et al.
Publicado: (1970)

Unusual presentation of a patient with complement deficiency and immunoglobulin deficiency
por: Manga, Vaishaali, et al.
Publicado: (2014)

Serum Immunoglobulin Levels and Complement Function of Tannery Workers in Bangladesh
por: Islam, Laila N., et al.
Publicado: (2019)

Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry
por: Abadeh, Armin, et al.
Publicado: (2023)

Microsatellite instability in patients with chronic B-cell lymphocytic leukaemia
por: Niv, E, et al.
Publicado: (2005)

Implication of Urinary Complement Factor H in the Progression of Immunoglobulin A Nephropathy
por: Liu, Maojing, et al.
Publicado: (2015)

Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension
por: Frid, Maria G., et al.
Publicado: (2020)

Efficacy of Preexposure Prophylaxis with Monoclonal-Antibody AZD7442 (tixagevimab-cilgavimab) Against Sars-Cov-2 Variants in Patients with CLL
por: Benjamini, Ohad, et al.
Publicado: (2022)

Time to Cure Hairy Cell Leukemia
por: Levy, Ilana, et al.
Publicado: (2017)

Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents
por: Tadmor, Tamar, et al.
Publicado: (2021)

MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level
por: Haring, Yael, et al.
Publicado: (2023)

INFECTIOUS VIRUS-ANTIBODY COMPLEXES: INTERACTION WITH ANTI-IMMUNOGLOBULINS, COMPLEMENT, AND RHEUMATOID FACTOR
por: Notkins, Abner Louis
Publicado: (1971)

Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice
por: Sylvestre, Diana, et al.
Publicado: (1996)

Neutrophils Require Activation to Express Functional Cell-Surface Complement Receptor Immunoglobulin
por: Small, Annabelle G., et al.
Publicado: (2022)

COMPLEMENT FIXATION BY A TWO-COMPONENT ANTIBODY SYSTEM: IMMUNOGLOBULIN G AND IMMUNOGLOBULIN M ANTI-GLOBULIN (RHEUMATOID FACTOR) : PARADOXICAL EFFECT RELATED TO IMMUNOGLOBULIN G CONCENTRATION
por: Schmid, Frank R., et al.
Publicado: (1970)

Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Platelet Activity and Bleeding Tendency in Patients with Gaucher Disease
por: Azoulay, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o3ehc7mnslg8hoh2hlkuk7nsor